This competitive renewal application is a continuation of our long-term effects to understand the role and mechanism of hepatocyte growth factor (HGF) and its c-met receptor in normal and diseased kidney. Studies in previous project period of this application suggest that HGF and its c-met receptor may play an important role in tubule survival, repair and regeneration as well as in the maintenance of tubular cell differentiated status in adult kidney. In this continuation application, we propose to create a conditional knockout mouse model, in which the c-met receptor gene is null-mutated specifically in renal tubular epithelial cells in the kidney. By using this model system, we will test the hypothesis that HGF/c-met is a major signaling system in the control of renal cell survival and differentiation in numerous physiologic and pathophysiologic settings. These studies will be accomplished in the three specific aims.
In aim 1, we will investigate the dependence of cell survival on cellular abundance of c-met receptor; and unravel the novel mechanism underlying HGF-independent cytoprotection of renal tubular epithelial cells by c-met receptor.
In aim 2, we will investigate the rate and extents of tubular cell death and renal functions in tubule-specific c-met conditional knockout mice both under normal conditions and after acute renal injury.
In aim 3, we will investigate and compare the phenotypes of renal tubular epithelia in tubule-specific c-met conditional knockout mice under normal conditions as well as in chronically injured kidney induced by unilateral ureteral obstruction. These studies will provide fundamental and important insights into understanding the mechanism controlling tubular cell survival, repair and differentiation under normal and diseased conditions. Ultimately, these studies may lead to development of novel strategies to alter the course of human renal disease by manipulating the activities of HGF/c-met signaling system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK054922-09
Application #
6899908
Study Section
General Medicine B Study Section (GMB)
Program Officer
Rasooly, Rebekah S
Project Start
1998-06-01
Project End
2007-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
9
Fiscal Year
2005
Total Cost
$254,971
Indirect Cost
Name
University of Pittsburgh
Department
Pathology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Giannopoulou, Myrto; Dai, Chunsun; Tan, Xiaoyue et al. (2008) Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling. Am J Pathol 173:30-41
Tan, Ruoyun; Zhang, Xianghong; Yang, Junwei et al. (2007) Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor. J Am Soc Nephrol 18:2340-9
Li, Yingjian; Yang, Junwei; Luo, Jian-Hua et al. (2007) Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1. J Am Soc Nephrol 18:449-60
Tan, Ruoyun; Zhang, Jinglan; Tan, Xiaoyue et al. (2006) Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation. J Am Soc Nephrol 17:2781-91
Hu, Kebin; Yang, Junwei; Tanaka, Sakae et al. (2006) Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J Biol Chem 281:2120-7
Giannopoulou, Myrto; Iszkula, Steven C; Dai, Chunsun et al. (2006) Distinctive role of Stat3 and Erk-1/2 activation in mediating interferon-gamma inhibition of TGF-beta1 action. Am J Physiol Renal Physiol 290:F1234-40
Liu, Youhua (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69:213-7
Li, Yingjian; Wen, Xiaoyan; Spataro, Bradley C et al. (2006) hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. J Am Soc Nephrol 17:54-65
Tan, Xiaoyue; Li, Yingjian; Liu, Youhua (2006) Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 17:3382-93
Xia, Jing-Lin; Dai, Chunsun; Michalopoulos, George K et al. (2006) Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 168:1500-12

Showing the most recent 10 out of 38 publications